Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126753481 | 12675348 | 1 | I | 20160817 | 20160822 | 20160822 | EXP | JP-009507513-1608JPN011012 | MERCK | 10.00 | YR | F | Y | 0.00000 | 20160822 | CN | IE | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126753481 | 12675348 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNKNOWN | U | U | 12675 | TABLET | |||||||
| 126753481 | 12675348 | 2 | SS | METHOTREXATE. | METHOTREXATE | 1 | Intrathecal | 12 MG, QD | U | 0 | 12 | MG | TABLET | QD | |||||
| 126753481 | 12675348 | 3 | SS | HYDROCORTISONE. | HYDROCORTISONE | 1 | Unknown | 25 MG, QD | U | 0 | 25 | MG | LOTION | QD | |||||
| 126753481 | 12675348 | 4 | SS | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | MINIMUM INHIBITORY CONCENTRATION: 2.0 RGN/L (UNKNOWN) | U | 0 | |||||||||
| 126753481 | 12675348 | 5 | SS | MEROPENEM. | MEROPENEM | 1 | Intravenous (not otherwise specified) | MINIMUM INHIBITORY CONCENTRATION: BELOW OR EQUAL TO 0.5 MG/L (UNKNOWN) | U | 0 | |||||||||
| 126753481 | 12675348 | 6 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | (UNKNOWN) 1200 MG, QD | U | 0 | QD | ||||||||
| 126753481 | 12675348 | 7 | SS | DAUNORUBICIN | DAUNORUBICIN | 1 | Unknown | (UNKNOWN) 40 MG | U | 0 | 40 | MG | QD | ||||||
| 126753481 | 12675348 | 8 | SS | COLONY STIMULATING FACTOR (UNSPECIFIED) | GRANULOCYTE COLONY-STIMULATING FACTOR NOS | 1 | Unknown | UNKNOWN | U | 0 | |||||||||
| 126753481 | 12675348 | 9 | SS | CYTARABINE. | CYTARABINE | 1 | Unknown | HIGH DOSE (4 GM) | U | 0 | 4 | G | QD | ||||||
| 126753481 | 12675348 | 10 | SS | CYTARABINE. | CYTARABINE | 1 | Intratracheal | 30 MG, QD | U | 0 | 30 | MG | QD | ||||||
| 126753481 | 12675348 | 11 | SS | ASPARAGINASE | ASPARAGINASE | 1 | Unknown | 6200 IU, QD | U | 0 | QD | ||||||||
| 126753481 | 12675348 | 12 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | Unknown | 2 MG, QD | 0 | 2 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126753481 | 12675348 | 1 | Acute lymphocytic leukaemia |
| 126753481 | 12675348 | 2 | Product used for unknown indication |
| 126753481 | 12675348 | 3 | Product used for unknown indication |
| 126753481 | 12675348 | 4 | Pseudomonas infection |
| 126753481 | 12675348 | 5 | Pseudomonas infection |
| 126753481 | 12675348 | 6 | Product used for unknown indication |
| 126753481 | 12675348 | 7 | Product used for unknown indication |
| 126753481 | 12675348 | 8 | Product used for unknown indication |
| 126753481 | 12675348 | 9 | Product used for unknown indication |
| 126753481 | 12675348 | 11 | Product used for unknown indication |
| 126753481 | 12675348 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126753481 | 12675348 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126753481 | 12675348 | Cellulitis gangrenous | |
| 126753481 | 12675348 | Neutropenia | |
| 126753481 | 12675348 | Pseudomonas infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |